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Investigation on the biochemical isomerization of 
ibuprofen led us to the successful purification of “2- 
arylpropionyl-CoA epimerase* from rat liver cytosol 
and mitochondria. The purified enzymes from both 
subcellular fractions exhibit similar physical and cat- 
alytic properties and are distinctly different from rat 
liver methylmalonyl-CoA epimerase. Both are mono- 
meric proteins with an apparent molecular mass of 42 
kDa and show similar contents of most amino acids. 
Their UV spectra gave no indication of any bound 
cofactors, and their enzyme activities  were not affected 
by exposure to  EDTA or metal ions (except Cu2+). These 
results suggest that the cytosolic and mitochondrial 
epimerases may  be structurally related. The purified 
enzymes catalyze the epimerization of various 2-aryl- 
propionyl-CoAs with some degree of stereochemical 
differentiation. For 2-(4-isobutylphenyl)propionyl- 
CoA, the equilibrium constant was estimated to be 1.5 
in favor of the R-isomer. Evidence indicated that the 
proton exchange may be mediated by a 2-base mecha- 
nism and that a carboxylic residue in the active  site 
may serve  as a general base for proton abstraction. 
The 2-arylpropionic acids are an important group of non- 
steroidal antiinflammatory drugs, commonly used for the 
treatment of pain, fever, and inflammation, as well as  other 
connective tissue and rheumatologic diseases. Their activity 
in inhibiting prostaglandin synthesis is mainly contributed 
by the S-enantiomers.  With the exception of naproxen, these 
therapeutic agents, such as ibuprofen and fenoprofen, are 
administered  as racemic mixtures. A unique feature regarding 
2-arylpropionic acid metabolism is the stereoselective conver- 
sion of the R-enantiomer to its  S-counterpart,  but  not vice 
versa (1). Such unidirectional inversion has been documented 
in many species of mammals, including humans (2, 3). This 
biochemical transformation leads to elevated serum levels of 
the active species and in essence accounts for a bioactivation 
process. Although this metabolic inversion may not  represent 
a potential pitfall for healthy individuals, it is of concern to 
those with asymptomatic kidney or liver dysfunction due to 
the suppression of renal prostaglandin synthesis (4-6). Inci- 
dences of acute kidney failure have been reported in metabol- 
ically compromised patients  after  short-term use of ibuprofen 
(7, 8). 
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FIG. 1. Mechanism of metabolic stereoisomeric inversion of 
2-arylpropionic acids. 
A generally accepted biochemical pathway for this meta- 
bolic event is shown in Fig. l (9). The step of acyl-CoA 
formation has been shown to play a pivotal role in controlling 
the overall stereoselectivity, with only the R-enantiomer con- 
verted to its CoA-thioester (10, 11). 
A putative enzyme, “2-arylpropionyl-CoA epimerase,”’ sub- 
sequently mediates a rapid interconversion between the R- 
and S-epimers which, upon the action of a thioesterase, yield 
the free acids. Previously, using rat liver and kidney homog- 
enates, we presented evidence indicating that  the epimeriza- 
tion of 2-(4-isobutylphenyl)propionic acid (ibuprofen) pro- 
ceeds  via this CoA-dependent proton  abstraction mechanism 
(3, 12). Yet, the identity  and biological function of this  puta- 
tive epimerase remain to be explored. In  this paper, we report 
the purification and characterization of 2-arylpropionyl-CoA 
epimerases from two subcellular fractions, cytosol and mito- 
chondria, of rat liver. 
EXPERIMENTAL  PROCEDURES 
Materials 
Racemic 2-(4-isobutylphenyl)propionic acid (ibuprofen) was pre- 
pared from  commercial ibuprofen  tablets  and purified by recrystalli- 
zation from petroleum ether. Racemic [2-2H]2-(4-isobutylphenyl)- 
propionic acid was synthesized via the deuterium exchange of the 
a-proton  with excess amounts of CH,OD in  the  presence of CH,ONa 
(13).  Optically  active 2-(4-isobutylphenyl)propionic acid and  its deu- 
terated  derivatives were prepared by the  enzymatic resolution of the 
corresponding racemic methyl  esters (13). The CoA thioesters were 
synthesized via the mixed anhydride  method  as described  previously 
(3).  The  diastereomeric excess (d .e . )  of chemically  synthesized 2-(4- 
isobutylpheny1)propionyLCoA was greater  than  95%. Calculation of 
the  diastereomeric composition  was based  on  the  equation, d.e. = ( A  
- B ) / ( A  + B ) ,  where A and B are  the  concentrations of the major 
and  minor isomers,  respectively. All chromatographic  materials, ex- 
cept hydroxylapatite, were purchased from Sigma. Hydroxylapatite 
gel was obtained  from  Spectrum Medical Industries, Inc. Other  chem- 
’ As the  natural  function of this  epimerase  remains  unknown,  the 
nomenclature is tentative. 
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icals and biochemicals were supplied from Sigma or Aldrich unless 
otherwise mentioned. 
Subcellular Fractionation 
An adult male Charles River Wistar rat, weighing 250-300  g, was 
sacrificed by decapitation after light ether anesthesia. The liver was 
removed,  minced, suspended in 2 volumes of ice-cold 100 mM potas- 
sium phosphate buffer, pH 7.0, containing 1 mM a-toluenesulfonyl 
fluoride, 1 mM EDTA, 0.25 M sucrose (Buffer A), and homogenized 
in a mechanically driven Teflon glass homogenizer (five vertical 
passes at low speed). The liver homogenate was centrifuged for 10 
min at 3,500 X g to prepare postnuclear supernatant. The mitochon- 
drial  and lysosomal fractions were prepared from postnuclear super- 
natant by density gradient methods (14). The postnuclear superna- 
tant was centrifuged at 10,000 X g for 10 min, and the resulting 
supernatant was further centrifuged at 100,000 X g for 1 h to yield 
the microsomal and cytosolic soluble fractions. All fractions were 
treated with Triton X-100 at a final concentration of 0.1% (w/v) 
before assay. The activities of the marker enzymes (lactate dehydro- 
genase, cytochrome c oxidase, and @-galactosidase) were analyzed 
according to  the procedures described by Storrie and Madden (14). 
2-Arylpropionyl-CoA Epimerase Assay 
Activities of the 2-arylpropionyl-CoA epimerase in all the enzyme 
preparations were assayed using an enantioselective HPLC' method 
as described previously (3) with slight modifications. The incubation 
mixture contained 100 mM potassium phosphate buffer, pH 7.0, 1 
mM EDTA (buffer B), a suitable amount of the enzyme, and 0.5 mM 
( S ) -  or (R)-2-(4-isobutylphenyl)propionyl-CoA in a final volume of 1 
ml. The enzyme reaction was started by the addition of substrate. 
After gentle shaking at 30  "C for 5 min, the reaction was terminated 
by adding 0.3 ml  of  2.5 M hydroxylamine solution, pH 7.0. Extraction 
of the resulting hydroxamic acid with ether, followed by 6 N HCl 
hydrolysis, afforded free 2-(4-isobutylphenyl)propionic acid. The acid 
was then converted to  the acyl chloride and then to  the corresponding 
(lR,PS,5R)-menthyl  ester. The diastereomeric composition was de- 
termined by HPLC. A control assay without enzyme addition was 
conducted simultaneously to determine the background value, which 
was subtracted. No background epimerization could be detected under 
these assay conditions. Enzyme activity was expressed as @moles of 
(R)-2-(4-isobutylphenyl)propionyl-CoA formed from the  S-substrate 
per min at 30 "C. 
Purification of 2-Arylpropionyl-CoA Epimerase from Rat Liver 
Cytosol and Mitochondria 
All operations were performed at 4 "C unless otherwise stated. The 
postnuclear supernatant was centrifuged at 10,000 x g for 10 min. 
The supernatant,  after  further centrifugation at 100,000 X g for 1 h, 
served as the source for the purification of the cytosolic epimerase. 
The 10,000 X g pellets that contained mostly mitochondria were 
washed with buffer A twice and resuspended in buffer B  containing 
1 mM a-toluenesulfonyl fluoride (buffer C ) .  The mitochondrial frac- 
tion was treated with Triton X-100 at a final concentration of 0.125% 
and was centrifuged at 30,000 X g for 15 min. The  supernatant was 
dialyzed against buffer C for 16 h and used for the isolation of the 
mitochondrial epimerase. Procedures for the purification of 2-aryl- 
propionyl-CoA epimerases from both fractions were similar except 
that gel filtration chromatography was not required for the mitochon- 
drial enzyme. 
Ammonium Sulfate Precipitation (Step 1)-Solid ammonium sul- 
fate was added to the supernatant  to 35% saturation while the  pH 
was maintained at 7.0 with 1 N ammonium hydroxide. After being 
stirred for  10 min, the preparation was centrifuged at 10,000 X g for 
20 min. The supernatant was brought to 65% saturation with solid 
ammonium sulfate, stirred for 10 min, and centrifuged as described 
ureviouslv. The ureciuitate was resusuended in 20 mM imidazole 
enzymes, respectively. The column was  washed with the same buffer 
until the absorbance at 280 nm returned to  the base line. The adsorbed 
protein was eluted with 50 mM NaCl and then with a linear salt 
gradient of  50-300 mM NaCl in the same buffer. The active fractions 
were  pooled, concentrated over a 10,000 cutoff ultrafiltration mem- 
brane (Filtron Omega unit) and dialyzed against 15 mM potassium 
phosphate, pH 7.0, for 16 h. 
Hydroxylapatite Chromatography (Step 3)"The dialyzed sample 
from step 2 was applied to the hydroxylapatite column equilibrated 
with 15 mM potassium phosphate buffer, pH 7.0. The column sizes 
were 2.5 X 13 and 2.5 X 8 cm for the cytosolic and mitochondrial 
enzymes, respectively. The adsorbed proteins were eluted with a linear 
gradient (15-100 mM) of potassium phosphate buffer, pH 7.0. Frac- 
tions exhibiting epimerase activity were collected, concentrated by 
ultrafiltration, and dialyzed against 20 mM sodium phosphate buffer, 
pH 7.0, containing ammonium sulfate with 12% saturation. 
Phenyl-Sepharose CL-4B Chromatography (Step 4)"The dialyzed 
sample from step 3 was applied onto a phenyl-Sepharose column 
equilibrated with the dialysis buffer. The column sizes for the cyto- 
solic and mitochondrial enzymes were 2.5 X 8 and 2.5 X 7 cm, 
respectively. A gradient of 12% saturation of ammonium sulfate to 
50% ethylene glycol in 20 mM sodium phosphate, pH 7.0, was used 
to elute the adsorbed proteins. The active fractions were pooled, 
concentrated,  and dialyzed against 10 mM sodium phosphate, pH 6.7, 
containing 50 mM NaCl. 
Red  Dye Affinity Chromatography (Step 5)"The dialyzed solution 
from step  4 was  loaded onto  a Reactive Red 120-agarose (type 3000- 
CL) column equilibrated with the dialysis buffer. The column sizes 
were 1.5 X 4 and 1.5 X 3.5 cm for the cytosolic and mitochondrial 
enzymes, respectively. Elution buffer was a gradient of 50-500 mM 
NaCl in 10 mM sodium phosphate, pH 6.7. 
Sephacryl S-200 Chromatography (Step 6)"The cytosolic epimer- 
ase from step 5 was concentrated to about 10 ml and further purified 
by a Sephacryl S-200 column (2.5 X 90 cm). The equilibration and 
eluting buffer was  50 mM Tris/HCl,  pH 7.5, containing 50 mM NaCI. 
Homogeneity and Molecular Mass Determinations 
The purity and molecular mass of the purified epimerase were 
analyzed by 12% polyacrylamide gels containing 0.1% SDS (SDS- 
polyacrylamide gel electrophoresis) according to the method described 
by Laemmli (15). The molecular mass standards were  bovine serum 
albumin (66,000 Da), ovalbumin (45,000 Da), glyceraldehyde-3-phos- 
phate dehydrogenase (36,000 Da), carbonic anhydrase (29,000 kDa), 
trypsinogen (24,000 Da), trypsin  inhibitor (20,100 Da),  and  a-lactal- 
bumin (14,200 Da). Gels  were stained with Coomassie Brilliant Blue 
after electrophoresis. The molecular mass was also estimated by  gel 
filtration chromatography on a sephacryl S-200 column (90 X 2.5 cm) 
equilibrated with 50 mM Tris/HCl, pH 7.5, containing 50 mM NaCl. 
Blue dextran (2,000,000 Da) was used to determine the void  volume. 
The proteins used as calibration standards were @-amylase (200,000 
Da), alcohol dehydrogenase (150,000 Da), bovine serum albumin 
(66,000 Da), carbonic anhydrase (29,000 Da), and cytochrome c 
(12,400 Da). 
Miscellaneous 
Protein determinations were performed using a Coomassie Blue 
dye-binding method (16) using a commercial reagent (Pierce Chemi- 
cal Co.) with bovine serum albumin as a  standard.  Protein concen- 
trations during purification were determined by measuring the ab- 
sorbance at 280 nm. The amino acid analyses were independently 
performed by the Protein/Nucleic Acid Shared Facility at the Medical 
College of Wisconsin and by the W. M. Keck Foundation Biotech- 
nology Resource Laboratory at Yale University. The results from 
both facilities were consistent. Low resolution electron impact and 
chemical ionization mass spectra were obtained on a Kratos MS- 
80RFA spectrometer, Chemical Instrument Center, Yale University. 
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method with (S)-2-(4-isobutylphenyl)propionyl-CoA as  sub- 
strate. As indicated by the relative specific activities of the 
marker enzymes (Table I), each subcellular fraction was en- 
riched after differential centrifugation. Although mitochon- 
dria  and lysosome  could not be completely separated by the 
metrizamide method (20), the epimerase activity in lysosome 
was negligible. The enzyme activity was located predomi- 
nantly in the cytosol (51%)  and mitochondria (30%),  and  to 
a lesser extent, in the microsomes (16%). It is interesting to 
note  that intact mitochondria prior to detergent treatment 
also mediated the epimerization reaction at rates comparable 
with those of Triton  X-100-treated mitochondria. 
Purification of 2-Arylpropionyl-CoA Epimerase from Mito- 
chondria and Cytosol-Enzyme purification from the cytosolic 
and mitochondrial fractions was similar except that  the cy- 
tosolic enzyme required an additional  step, Sephacryl S-200 
column chromatography, to achieve homogeneity (Table 11). 
The overall procedures resulted in a 3,500-fold purification 
for the cytosolic epimerase and  a 1,600-fold purification for 
the mitochondrial enzyme. The low increases in specific ac- 
tivity during the  initial  steps might be caused by the interfer- 
ence of thioesterase(s) during the assays. With (S)-2-(4- 
isobutylpheny1)propionyl-CoA as substrate, the specific ac- 
tivities were  410 and 600 pmol/min/mg protein for the cyto- 
solic and mitochondria enzymes, respectively. 
Purity  and Molecular  Mass-The  degree of purity of both 
enzyme preparations was assessed by SDS-polyacrylamide gel 
electrophoresis (Fig. 2). Both enzyme preparations gave a 
single protein band with a molecular mass of 42,000 Da. The 
native molecular masses of these two enzymes were estimated 
to  be  40,000  Da  by  gel filtration on Sephacryl S-200 (data  not 
shown), indicating that both epimerases are monomeric pro- 
teins. 
Enzyme Properties-The purified enzyme, from either cy- 
tosol or mitochondria, became inactivated after freezing and 
thawing. Thus, the enzyme preparations were stored at 4 "C 
in 10 mM potassium phosphate buffer containing  5% ethylene 
glycol and 0.02% NaN3. Heat  treatments resulted in irrevers- 
ible inactivation of the enzyme. At  50 "C, tllz for inactivation 
was about 5 min. When the enzyme was treated at 80 "C for 
the same period of time, complete loss of activity was noted, 
Optimal  pH was studied in the  pH range of  4.5-9.5. Epimerase 
activity rose sharply between pH 4.5 and 5.0 and reached a 
plateau from pH 5.5 through pH 9.5. (Fig. 3). Study at pH 
higher than 9.5 was prohibited for two reasons. First, the 
thioester bond hydrolyzes spontaneously at  pH values greater 
than 10; second, as the pK,  of the  a-methine proton is about 
10.3 (12), chemical epimerization becomes significant at such 
a high pH. 
Amino  Acid  Composition-The amino acid compositions of 
both epimerase preparations are shown in Table 111. Both 
enzymes are rich in Glx,  Gly, and Leu but low in Cys, Met, 
Tyr, His, and Trp contents. The (Glx + Asx)/(Lys + Arg) 
ratios are 2.0 and 2.1 for the cytosolic and mitochondrial 
enzymes, respectively, indicating the acidic nature of the 
proteins. This is consistent with the PI value of the cytosolic 
epimerase, which was determined to be 5.5 by isoelectric 
focusing electrophoresis. 
Cofactor  Requirements-Our study indicated that no  exog- 
enous cofactor is required for the epimerase activity. The 
spectra of these two  enzyme preparations showed  no absorp- 
tion  other than  that attributable to  the protein. Addition of 
NAD(P)+, FAD, or FMN did not increase the activity. No 
change in activity occurred upon treatment with EDTA (0.5 
mM) or various metal ions (0.5 mM) including Ni2+, M e ,  
Co2+, Fe3', Fez+, Mn2+, and Zn2+.  However, preincubation of 
cytosolic or mitochondrial 2-arylpropionyl-CoA epimerase 
with 0.5 mM Cu2+ in 100 mM potassium phosphate buffer, pH 
7.0, at 30 "C for 10 min resulted in 65 and 70% loss of the 
activity, respectively. 
Substrate Specificity and Approach Equilibrium Study- 
The purified epimerase, either of cytosolic or mitochondrial 
origin, catalyzed the epimerization of both ( S ) -  and  (R)-2-(4- 
isobutylpheny1)propionyl-CoA. No racemization could  be de- 
tected with the corresponding free acids as  substrate. Using 
the mitochondrial enzyme, the  apparent  initial  rates of epi- 
merization were  1,120 and 3,180 pmol/min/mg protein for the 
( R ) -  and (S)-2-(4-isobutylphenyl)propionyl-CoA, respec- 
tively. The reactions reached an equilibrium in favor of the 
(R)-isomer from either directions (Fig. 4). The diastereomeric 
excess of the product was calculated to be 0.2, which is 
consistent with the value determined previously using crude 
liver homogenates (3). Accordingly, the equilibrium constant 
(I&) is estimated  to be  1.5. 
Besides the above CoA thioesters, 2-arylpropionyl-CoA epi- 
merase can also utilizes (S)-2-phenylpropionyl-CoA and ( S ) -  
2-(6-methoxynaphthyl)propionyl-CoA at rates comparable to 
that of (S)-2-(4-isobutylphenyl)propionyl-CoA. 
a-Proton Exchange-To assess the mechanism of proton 
exchange in the catalytic site, (R)-2-[2-ZH]-(4-Isobutyl- 
pheny1)propionyl-CoA  was used as  substrate for  cytosolic 2- 
arylpropionyl-CoA epimerase. After 20% conversion, the re- 
action was terminated by hydroxylamine at pH 7.0. The ( R ) -  
and (S)-isomers were separated as diastereomeric menthyl 
esters by HPLC  and analyzed by mass spectrometry. Virtually 
no deuterium was found attached to  the S-epimer product, 
indicating that  the hydrogen atom of the new C-H bond is 
derived from the solvent protons. 
DISCUSSION 
The enzyme responsible for the epimerization of 2-arylpro- 
pionyl-CoA was purified to homogeneity from rat liver  cytosol 
TABLE I 
Subcellular  distribution of marker  enzymes  and  2-arylpropionyl-CoA  epimerase  activity  in the rat liver 
Relative specific activities of marker enzymes 2-Arylpropionyl-CoA epimerase 
Subcellular fraction Lactate Cytochrome e 
dehydrogenase oxidase 0-Galactosidase Total activitg Distribution 
units % 
Postnuclear supernatant 1 1 1 615 
Cytosol 
Mitochondria 
1.71 0.17 0.13 454 
0.16 6.0 
Lysosome 0 
Microsomes 0.19 
31 
51 
2.6 265  30 
3 
0.58 144  16 
1.5 13.3 
0.80 
Total activity was  measured  from each subcellular fraction isolated from  rat  liver postnuclear supernatant containing 1430 mg of protein. 
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TABLE I1
Purification of 2-arylpropionyl-CoA  epimerases f rom rat  liver cytosol and  mitochondria 
Cytosolic epimerase Mitochondrial epimerase 
mg units units/mg - /Old w units unitslny -fold 
Crude homogenate 11,420  1,366  0.12 1 428 160 0.37 1 
Ammonium sulfate (35-65%) 2,844 512 0.18  1.5 96 119 1.24  3.3 
DEAE-Sepharose 358 261 0.73  6 60 96 1.6  4.3 
Hydroxylapatite 70 252  3.6 30 18 98 5.4 14 
Phenyl-Sepharose 4.8  175  36 300 5.4 70  13  35 
Red  dye  gel 0.26  52  200  1,700  0.036 11 600 1,600 
Sephacryl S-200 0.11  46  410  3,500 
1 2 3  KDa 
-66 
- 45 
- 36 
- 29 - 24 
- 20.1 
- 14.2 
FIG. 2. SDS-polyacrylamide gel electrophoresis of purified 
2-arylpropionyl-CoA epimerase. The  proteins were analyzed on 
a 12% gel. Lane I, the mitochondrial epimerase; lane 2, the  cytosolic 
epimerase; lane 3, molecular mass standards. 
and mitochondria  with  high purification folds. This purifica- 
tion  represents  the  first  preparation of such an  epimerase  in 
highly  purified form. Several lines of physical and  mechanistic 
evidence  indicate that  this 2-arylpropionyl-CoA epimerase  is 
distinctively different from methylmalonyl-CoA epimerase 
(21)  (Table IV) and  many  other known epimerases  reported 
in  the  rat liver. However, a t  present,  one  cannot exclude that 
the epimerase is a known protein with multiple enzymatic 
functions. To investigate this possibility, elucidation of the 
protein sequence is  currently in  progress. 
I t  is interesting  to  note  that  the  epimerase  activity is located 
in both cytosol and mitochondria. The purified proteins from 
both  fractions  exhibit  similar physical and  catalytic  proper- 
ties.  Their  chromatographic  behaviors were nearly identical 
throughout the purification. Both are monomeric proteins 
with an apparent molecular mass of 42,000 Da. Their UV 
spectra gave no  indication of bound  pyridine  or flavin  nucle- 
osides, and  the enzyme activity was not affected by exposure 
to  EDTA  or  metal ions except Cu2+.  Amino  acid compositions 
indicated  that  both  epimerases  had  similar  contents in most 
of the amino acids except Ser, Gly, and Leu. Attempts to 
determine the N-terminal sequences of these two proteins 
1.00 - 
0.80 - 
'5 
3 
w 
' 3  
2 
'a 
0.60 - 
0.40 - 
pH 
FIG. 3. Effect of pH on 2-arylpropionyl-CoA epimerase. The 
activities of the purified cytosolic epimerase were determined after 8- 
min preincubations at 30 "C with  the following buffers: 0.1 M citrate 
buffer at pH 4.5-6.0; 0.1 M potassium phosphate buffer at pH 6.5, 
7.0, and 7.5;  0.1 M Tris buffer at pH 8.0 and 8.5;  0.1 M glycine buffer 
at pH 9.0 and 9.5. No appreciable nonenzymatic epimerization was 
detected at these  pH values. 
TABLE 111 
Amino acid compositions of 2-arylpropionyl-CoA  epimerases from rat 
liver cvtosol and  mitochondria 
Amino acid Cytosolic Mitochondrial 
epimerase epimerase 
Cysteine/cystine 
Aspartic acid/asparagine 
Threonine 
Serine 
Glutamic acid/glutamine 
Proline 
Glycine 
Alanine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Tryptophan 
Arginine 
1.7 
8.4 
3.9 
5.7 
12.0 
4.2 
11.1 
8.9 
5.2 
1.9 
3.4 
12.8 
2.7 
4.6 
2.7 
5.6 
0.7 
4.7 
mol% 
1.6 
7.7 
4.3 
7.6 
10.9 
5.1 
14.7 
8.6 
5.5 
2.1 
3.4 
10.3 
2.2 
4.1 
2.3 
4.6 
0.8 
4.3 
were unsuccessful, presumably due to the posttranslational 
blockage at   the  N termini.  These  results clearly  suggest that 
the cytosolic and mitochondrial epimerases are structurally 
related. I t  is well understood that although mitochondria 
contain their own genetic information, most mitochondrial 
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1 .oo 
It is worth noting that mitochondria with an  intact mem- 0.50 
discrepancy in the amino acid compositions. To clarify this 
0.75 A 
speculation, the protein sequences of both enzymes are cur- 
rently being examined. 
brane structure can mediate the epimerization reaction. As 
0.25 : 3 acyl-CoA thioesters can readily penetrate the outer membrane 
but  not the inner membrane of mitochondria (23), we specu- 
late that the epimerase may reside in the intermembrane 
””“””~”~”“””“” 
0.25 50v B space. The epimerization of 2-(4-isobutylphenyl)propionyl-CoA is freely reversible from both directions. Some  degree of stereo- 
0.751 , . , , , , , . , , , , , , , . . , [  
1 .oo 
chemical discrimination was  observed in  the substrate utili- 
zation and product formation of the epimerase reaction. As 
shown in the approach equilibrium study (Fig. 4), the S- 
Time (mind parent  initial  rate for (R)-2-(4-isobutvl~henvl)~ro~ionvl-CoA 
O 15 30 45 60 75 90 isomer is preferentially epimerized by the enzyme. The  ap- 
FIG. 4. Approach equilibrium profile. Curves A and E repre- 
sent time-dependent enzymatic inversion of ( R ) -  or  (S)-2-(4-isobu- 
tylpheny1)propionyl-CoA, respectively. The reaction mixture con- 
tained 0.5 mM substrate, 1 pg of purified mitochondrial epimerase, 
and 100 mM potassium phosphate, pH 7.0, in a final volume of 12 ml. 
At various intervals, 1-ml aliquots were withdrawn and added to tubes 
containing 0.3 ml of  0.25 M hydroxylamine, pH 7.0. The enantiomeric 
composition of the resulting product was determined according to  the 
method described under “Experimental Procedures.” 
TABLE IV 
Enzymatic  properties of 2-arylpropionyl-CoA  epimerase  versus 
methylmalonyl-CoA  epimerase 
Enzyme properties 2-Arylpropionyl-CoA Methylmalonyl-CoA 
eoimerase eoimerase 
Molecular weight 42,000 32,000 
Subunit  structure Monomeric Dimeric 
Cofactor requirement None 
Effect of EDTA 
Metal ions (e.g. Co2+) 
None Inactivation 
pH oDtimum 5.5-9.5 7.0 
ENZ- B 
I 
H+ 
Re face Si face 
FIG. 5. Enantiofacial differentiation in proton transfer to 
the aci thioester. 
proteins  are coded for by nuclear genes and synthesized in 
the cytosol. The precursor proteins  containing  targeting se- 
quences are  posttranslationally imported into mitochondria 
where the targeting sequences are hydrolyzed by a signal- 
associatedpeptidase (22). Thus,  it is possible that  the cytosolic 
epimerase differs from its mitochondrial counterpart by in- 
cluding a  short  targeting sequence that may account for the 
” - . -  - - 
relative to  that of the S-antipode was 35%. Based on the 
Haldane relationship (241, (Keq = (k~.t/K,)(S)/(k~at/Km)(R) = 
[ R ] / [ S ] ) ,  this result is consistent with the finding that  the 
diastereomeric composition at equilibrium lies favoring the 
R-isomer ( d e .  = 0.2). Accordingly, the equilibrium constant 
(I&) was estimated to be 1.5. For many chemically symmet- 
rical reactions mediated by racemases, the equilibrium con- 
stants are found to be unity  (25). However, it should be noted 
that for the epimerization between two diastereomers, this 
rule may not hold. 
In general, epimerase- or racemase-catalyzed proton ex- 
change can be accounted for by either single-base or 2-base 
acceptor mechanism (26). Our experiments indicate that  par- 
tial enzymatic epimerization of (R)-[2-2H]-2-(4-isobutyl- 
pheny1)propionyl-CoA gave the S-product completely de- 
pleted of the a-deuterium. This result provides supporting 
evidence for the 2-base mechanism. Moreover, the  pH profile 
study shows a  sharp rise in activity about pH 5.0 followed  by 
a  pH-independent  plateau  running from pH 5.5 to 9.5, sug- 
gesting that a carboxylic residue (Asp or Glu) may serve as  a 
general base in the active site for proton abstraction. Cur- 
rently, the nature of the amino acid residues involved in 
proton  transfer is being investigated by the chemical modifi- 
cation of the active site. Because metal ions are  not required 
for the catalysis, the unstable carbanion may  be stabilized as 
the aci tautomer with an extended conjugated system (26). It 
appears that  the reprotonation  takes place in favor of the Si- 
face of the aci thioester, resulting in the formation of the 
product enriched in the R-isomer (Fig. 5). This enantiofacial 
differentiation may be attributed  to  the steric and/or stereoe- 
lectronic effects imposed by the CoA moiety of the molecule. 
In conclusion, the significance of 2-arylpropionyl-CoA epi- 
merase is  2-fold. First,  this epimerase-mediated reaction rep- 
resents a novel biocatalysis with unknown biological func- 
tions.  Understanding of the molecular and mechanistic details 
of this new enzyme system may broaden our  knowledge  in the 
area of biochemical isomerization. Second, it plays a crucial 
role in the metabolic bioactivation of 2-arylpropionic acid 
nonsteroidal antiinflammatory drugs. The kinetic behavior of 
this epimerase may directly contribute to  the toxicity of some 
members of these therapeutic  agents  and  warrants  attention. 
At present, the structural and kinetic properties of these 
epimerases are being actively investigated. 
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